atc_level_01_code,atc_level_02_code,atc_level_03_code,atc_level_04_code,atc_level_05_code,atc_level_01_name,atc_level_02_name,atc_level_03_name,atc_level_04_name,atc_level_05_name
QL,QL01,QL01A,QL01AA,QL01AA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,cyclophosphamide
QL,QL01,QL01A,QL01AA,QL01AA02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,chlorambucil
QL,QL01,QL01A,QL01AA,QL01AA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,melphalan
QL,QL01,QL01A,QL01AA,QL01AA05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,chlormethine
QL,QL01,QL01A,QL01AA,QL01AA06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,ifosfamide
QL,QL01,QL01A,QL01AA,QL01AA07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,trofosfamide
QL,QL01,QL01A,QL01AA,QL01AA08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,prednimustine
QL,QL01,QL01A,QL01AA,QL01AA09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,bendamustine
QL,QL01,QL01A,QL01AA,QL01AA10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,melphalan flufenamide
QL,QL01,QL01A,QL01AB,QL01AB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Alkyl sulfonates,busulfan
QL,QL01,QL01A,QL01AB,QL01AB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Alkyl sulfonates,treosulfan
QL,QL01,QL01A,QL01AB,QL01AB03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Alkyl sulfonates,mannosulfan
QL,QL01,QL01A,QL01AC,QL01AC01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Ethylene imines,thiotepa
QL,QL01,QL01A,QL01AC,QL01AC02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Ethylene imines,triaziquone
QL,QL01,QL01A,QL01AC,QL01AC03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Ethylene imines,carboquone
QL,QL01,QL01A,QL01AD,QL01AD01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrosoureas,carmustine
QL,QL01,QL01A,QL01AD,QL01AD02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrosoureas,lomustine
QL,QL01,QL01A,QL01AD,QL01AD03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrosoureas,semustine
QL,QL01,QL01A,QL01AD,QL01AD04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrosoureas,streptozocin
QL,QL01,QL01A,QL01AD,QL01AD05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrosoureas,fotemustine
QL,QL01,QL01A,QL01AD,QL01AD06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrosoureas,nimustine
QL,QL01,QL01A,QL01AD,QL01AD07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrosoureas,ranimustine
QL,QL01,QL01A,QL01AD,QL01AD08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrosoureas,uramustine
QL,QL01,QL01A,QL01AG,QL01AG01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Epoxides,etoglucid
QL,QL01,QL01A,QL01AX,QL01AX01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Other alkylating agents,mitobronitol
QL,QL01,QL01A,QL01AX,QL01AX02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Other alkylating agents,pipobroman
QL,QL01,QL01A,QL01AX,QL01AX03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Other alkylating agents,temozolomide
QL,QL01,QL01A,QL01AX,QL01AX04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Other alkylating agents,dacarbazine
QL,QL01,QL01B,QL01BA,QL01BA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,methotrexate
QL,QL01,QL01B,QL01BA,QL01BA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,raltitrexed
QL,QL01,QL01B,QL01BA,QL01BA04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,pemetrexed
QL,QL01,QL01B,QL01BA,QL01BA05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,pralatrexate
QL,QL01,QL01B,QL01BB,QL01BB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Purine analogues,mercaptopurine
QL,QL01,QL01B,QL01BB,QL01BB03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Purine analogues,tioguanine
QL,QL01,QL01B,QL01BB,QL01BB04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Purine analogues,cladribine
QL,QL01,QL01B,QL01BB,QL01BB05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Purine analogues,fudarabine
QL,QL01,QL01B,QL01BB,QL01BB06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Purine analogues,clofarabine
QL,QL01,QL01B,QL01BB,QL01BB07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Purine analogues,nelarabine
QL,QL01,QL01B,QL01BB,QL01BB90,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Purine analogues,rabacfosadine
QL,QL01,QL01B,QL01BC,QL01BC01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,cytarabine
QL,QL01,QL01B,QL01BC,QL01BC02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,fluorouracil
QL,QL01,QL01B,QL01BC,QL01BC03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,tegafur
QL,QL01,QL01B,QL01BC,QL01BC04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,carmofur
QL,QL01,QL01B,QL01BC,QL01BC05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,gemcitabine
QL,QL01,QL01B,QL01BC,QL01BC06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,capecitabine
QL,QL01,QL01B,QL01BC,QL01BC07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,azacitidine
QL,QL01,QL01B,QL01BC,QL01BC08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,decitabine
QL,QL01,QL01B,QL01BC,QL01BC09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,floxuridine
QL,QL01,QL01B,QL01BC,QL01BC52,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,"fluorouracil, combinations"
QL,QL01,QL01B,QL01BC,QL01BC53,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,"tegafur, combinations"
QL,QL01,QL01B,QL01BC,QL01BC58,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,"decitabine, combinations"
QL,QL01,QL01B,QL01BC,QL01BC59,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,"trifluridine, combinations"
QL,QL01,QL01C,QL01CA,QL01CA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,vinblastine
QL,QL01,QL01C,QL01CA,QL01CA02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,vincristine
QL,QL01,QL01C,QL01CA,QL01CA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,vindesine
QL,QL01,QL01C,QL01CA,QL01CA04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,vinorelbine
QL,QL01,QL01C,QL01CA,QL01CA05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,vinflunine
QL,QL01,QL01C,QL01CA,QL01CA06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,vintafolide
QL,QL01,QL01C,QL01CB,QL01CB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Podophyllotoxin derivatives,etoposide
QL,QL01,QL01C,QL01CB,QL01CB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Podophyllotoxin derivatives,teniposide
QL,QL01,QL01C,QL01CC,QL01CC01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Colchicine derivatives,demecolcine
QL,QL01,QL01C,QL01CD,QL01CD01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,paclitaxel
QL,QL01,QL01C,QL01CD,QL01CD02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,docetaxel
QL,QL01,QL01C,QL01CD,QL01CD03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,paclitaxel poliglumex
QL,QL01,QL01C,QL01CD,QL01CD04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,cabazitaxel
QL,QL01,QL01C,QL01CD,QL01CD51,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,paclitaxel and encequidar
QL,QL01,QL01C,QL01CE,QL01CE01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Topoisomerase 1 (TOP1) inhibitors,topotecan
QL,QL01,QL01C,QL01CE,QL01CE02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Topoisomerase 1 (TOP1) inhibitors,irinotecan
QL,QL01,QL01C,QL01CE,QL01CE03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Topoisomerase 1 (TOP1) inhibitors,etirinotecan pegol
QL,QL01,QL01C,QL01CE,QL01CE04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Topoisomerase 1 (TOP1) inhibitors,belotecan
QL,QL01,QL01C,QL01CX,QL01CX01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Other plant alkaloids and natural products,trabectedin
QL,QL01,QL01D,QL01DA,QL01DA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Actinomycines,dactinomycin
QL,QL01,QL01D,QL01DB,QL01DB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,doxorubicin
QL,QL01,QL01D,QL01DB,QL01DB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,daunorubicin
QL,QL01,QL01D,QL01DB,QL01DB03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,epirubicin
QL,QL01,QL01D,QL01DB,QL01DB04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,aclarubicin
QL,QL01,QL01D,QL01DB,QL01DB05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,zorubicin
QL,QL01,QL01D,QL01DB,QL01DB06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,idarubicin
QL,QL01,QL01D,QL01DB,QL01DB07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,mitoxantrone
QL,QL01,QL01D,QL01DB,QL01DB08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,pirarubicin
QL,QL01,QL01D,QL01DB,QL01DB09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,valrubicin
QL,QL01,QL01D,QL01DB,QL01DB10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,amrubicin
QL,QL01,QL01D,QL01DB,QL01DB11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,pixantrone
QL,QL01,QL01D,QL01DC,QL01DC01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Other cytotoxic antibiotics,bleomycin
QL,QL01,QL01D,QL01DC,QL01DC02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Other cytotoxic antibiotics,plicamycin
QL,QL01,QL01D,QL01DC,QL01DC03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Other cytotoxic antibiotics,mitomycin
QL,QL01,QL01D,QL01DC,QL01DC04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Other cytotoxic antibiotics,ixabepilone
QL,QL01,QL01E,QL01EA,QL01EA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors,imatinib
QL,QL01,QL01E,QL01EA,QL01EA02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors,dasatinib
QL,QL01,QL01E,QL01EA,QL01EA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors,nilotinib
QL,QL01,QL01E,QL01EA,QL01EA04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors,bosutinib
QL,QL01,QL01E,QL01EA,QL01EA05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors,ponatinib
QL,QL01,QL01E,QL01EA,QL01EA06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors,asciminib
QL,QL01,QL01E,QL01EB,QL01EB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,gefitinib
QL,QL01,QL01E,QL01EB,QL01EB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,erlotinib
QL,QL01,QL01E,QL01EB,QL01EB03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,afatinib
QL,QL01,QL01E,QL01EB,QL01EB04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,osimertinib
QL,QL01,QL01E,QL01EB,QL01EB05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,rociletinib
QL,QL01,QL01E,QL01EB,QL01EB06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,olmutinib
QL,QL01,QL01E,QL01EB,QL01EB07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,dacomitinib
QL,QL01,QL01E,QL01EB,QL01EB08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,icotinib
QL,QL01,QL01E,QL01EB,QL01EB09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,lazertinib
QL,QL01,QL01E,QL01EB,QL01EB10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,mobocertinib
QL,QL01,QL01E,QL01EB,QL01EB11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,aumolertinib
QL,QL01,QL01E,QL01EC,QL01EC01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,B-Raf serine-threonine kinase (BRAF) inhibitors,vemurafenib
QL,QL01,QL01E,QL01EC,QL01EC02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,B-Raf serine-threonine kinase (BRAF) inhibitors,dabrafenib
QL,QL01,QL01E,QL01EC,QL01EC03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,B-Raf serine-threonine kinase (BRAF) inhibitors,encorafenib
QL,QL01,QL01E,QL01ED,QL01ED01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Anaplastic lymphoma kinase (ALK) inhibitors,crizotinib
QL,QL01,QL01E,QL01ED,QL01ED02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Anaplastic lymphoma kinase (ALK) inhibitors,ceritinib
QL,QL01,QL01E,QL01ED,QL01ED03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Anaplastic lymphoma kinase (ALK) inhibitors,alectinib
QL,QL01,QL01E,QL01ED,QL01ED04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Anaplastic lymphoma kinase (ALK) inhibitors,brigatinib
QL,QL01,QL01E,QL01ED,QL01ED05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Anaplastic lymphoma kinase (ALK) inhibitors,lorlatinib
QL,QL01,QL01E,QL01EE,QL01EE01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mitogen-activated protein kinase (MEK) inhibitors,trametinib
QL,QL01,QL01E,QL01EE,QL01EE02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mitogen-activated protein kinase (MEK) inhibitors,cobimetinib
QL,QL01,QL01E,QL01EE,QL01EE03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mitogen-activated protein kinase (MEK) inhibitors,binimetinib
QL,QL01,QL01E,QL01EE,QL01EE04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mitogen-activated protein kinase (MEK) inhibitors,selumetinib
QL,QL01,QL01E,QL01EF,QL01EF01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Cyclin-dependent kinase (CDK) inhibitors,palbociclib
QL,QL01,QL01E,QL01EF,QL01EF02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Cyclin-dependent kinase (CDK) inhibitors,ribociclib
QL,QL01,QL01E,QL01EF,QL01EF03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Cyclin-dependent kinase (CDK) inhibitors,abemaciclib
QL,QL01,QL01E,QL01EG,QL01EG01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mammalian target of rapamycin (mTOR) kinase inhibitors,temsirolimus
QL,QL01,QL01E,QL01EG,QL01EG02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mammalian target of rapamycin (mTOR) kinase inhibitors,everolimus
QL,QL01,QL01E,QL01EG,QL01EG03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mammalian target of rapamycin (mTOR) kinase inhibitors,ridaforolimus
QL,QL01,QL01E,QL01EG,QL01EG04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mammalian target of rapamycin (mTOR) kinase inhibitors,sirolimus
QL,QL01,QL01E,QL01EH,QL01EH01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,lapatinib
QL,QL01,QL01E,QL01EH,QL01EH02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,neratinib
QL,QL01,QL01E,QL01EH,QL01EH03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,tucatinib
QL,QL01,QL01E,QL01EJ,QL01EJ01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Janus-associated kinase (JAK) inhibitors,ruxolitinib
QL,QL01,QL01E,QL01EJ,QL01EJ02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Janus-associated kinase (JAK) inhibitors,fedratinib
QL,QL01,QL01E,QL01EJ,QL01EJ03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Janus-associated kinase (JAK) inhibitors,pacritinib
QL,QL01,QL01E,QL01EJ,QL01EJ04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Janus-associated kinase (JAK) inhibitors,momelotinib
QL,QL01,QL01E,QL01EK,QL01EK01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,axitinib
QL,QL01,QL01E,QL01EK,QL01EK02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,cediranib
QL,QL01,QL01E,QL01EK,QL01EK03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,tivozanib
QL,QL01,QL01E,QL01EK,QL01EK04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,fruquintinib
QL,QL01,QL01E,QL01EL,QL01EL01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Bruton's tyrosine kinase (BTK) inhibitors,ibrutinib
QL,QL01,QL01E,QL01EL,QL01EL02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Bruton's tyrosine kinase (BTK) inhibitors,acalabrutinib
QL,QL01,QL01E,QL01EL,QL01EL03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Bruton's tyrosine kinase (BTK) inhibitors,zanubrutinib
QL,QL01,QL01E,QL01EL,QL01EL04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Bruton's tyrosine kinase (BTK) inhibitors,orelabrutinib
QL,QL01,QL01E,QL01EL,QL01EL05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Bruton's tyrosine kinase (BTK) inhibitors,pirtobrutinib
QL,QL01,QL01E,QL01EM,QL01EM01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,idelalisib
QL,QL01,QL01E,QL01EM,QL01EM02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,copanlisib
QL,QL01,QL01E,QL01EM,QL01EM03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,alpelisib
QL,QL01,QL01E,QL01EM,QL01EM04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,duvelisib
QL,QL01,QL01E,QL01EM,QL01EM05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,parsaclisib
QL,QL01,QL01E,QL01EN,QL01EN01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,erdafitinib
QL,QL01,QL01E,QL01EN,QL01EN02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,pemigatinib
QL,QL01,QL01E,QL01EN,QL01EN03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,infigratinib
QL,QL01,QL01E,QL01EN,QL01EN04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,futibatinib
QL,QL01,QL01E,QL01EX,QL01EX01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,sunitinib
QL,QL01,QL01E,QL01EX,QL01EX02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,sorafenib
QL,QL01,QL01E,QL01EX,QL01EX03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,pazopanib
QL,QL01,QL01E,QL01EX,QL01EX04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,vandetanib
QL,QL01,QL01E,QL01EX,QL01EX05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,regorafenib
QL,QL01,QL01E,QL01EX,QL01EX06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,masitinib
QL,QL01,QL01E,QL01EX,QL01EX07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,cabozantinib
QL,QL01,QL01E,QL01EX,QL01EX08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,lenvatinib
QL,QL01,QL01E,QL01EX,QL01EX09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,nintedanib
QL,QL01,QL01E,QL01EX,QL01EX10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,midostaurin
QL,QL01,QL01E,QL01EX,QL01EX11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,quizartinib
QL,QL01,QL01E,QL01EX,QL01EX12,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,larotrectinib
QL,QL01,QL01E,QL01EX,QL01EX13,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,gilteritinib
QL,QL01,QL01E,QL01EX,QL01EX14,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,entrectinib
QL,QL01,QL01E,QL01EX,QL01EX15,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,pexidartinib
QL,QL01,QL01E,QL01EX,QL01EX17,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,capmatinib
QL,QL01,QL01E,QL01EX,QL01EX18,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,avapritinib
QL,QL01,QL01E,QL01EX,QL01EX19,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,ripretinib
QL,QL01,QL01E,QL01EX,QL01EX21,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,tepotinib
QL,QL01,QL01E,QL01EX,QL01EX22,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,selpercatinib
QL,QL01,QL01E,QL01EX,QL01EX23,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,pralsetinib
QL,QL01,QL01E,QL01EX,QL01EX24,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,surufatinib
QL,QL01,QL01E,QL01EX,QL01EX25,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,umbralisib
QL,QL01,QL01E,QL01EX,QL01EX26,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,sitravatinib
QL,QL01,QL01E,QL01EX,QL01EX27,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,capivasertib
QL,QL01,QL01E,QL01EX,QL01EX90,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors,toceranib
QL,QL01,QL01F,QL01FA,QL01FA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD20 (Clusters of Differentiation 20) inhibitors,rituximab
QL,QL01,QL01F,QL01FA,QL01FA02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD20 (Clusters of Differentiation 20) inhibitors,ofatumumab
QL,QL01,QL01F,QL01FA,QL01FA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD20 (Clusters of Differentiation 20) inhibitors,obinutuzumab
QL,QL01,QL01F,QL01FB,QL01FB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD22 (Clusters of Differentiation 22) inhibitors,inotuzumab ozogamicin
QL,QL01,QL01F,QL01FB,QL01FB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD22 (Clusters of Differentiation 22) inhibitors,moxetumomab pasudotox
QL,QL01,QL01F,QL01FC,QL01FC01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD38 (Clusters of Differentiation 38) inhibitors,daratumumab
QL,QL01,QL01F,QL01FC,QL01FC02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD38 (Clusters of Differentiation 38) inhibitors,isatuximab
QL,QL01,QL01F,QL01FD,QL01FD01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,trastuzumab
QL,QL01,QL01F,QL01FD,QL01FD02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,pertuzumab
QL,QL01,QL01F,QL01FD,QL01FD03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,trastuzumab emtansine
QL,QL01,QL01F,QL01FD,QL01FD04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,trastuzumab deruxtecan
QL,QL01,QL01F,QL01FD,QL01FD05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,trastuzumab duocarmazine
QL,QL01,QL01F,QL01FD,QL01FD06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,margetuximab
QL,QL01,QL01F,QL01FE,QL01FE01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,EGFR (Epidermal Growth Factor Receptor) inhibitors,cetuximab
QL,QL01,QL01F,QL01FE,QL01FE02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,EGFR (Epidermal Growth Factor Receptor) inhibitors,panitumumab
QL,QL01,QL01F,QL01FE,QL01FE03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,EGFR (Epidermal Growth Factor Receptor) inhibitors,necitumumab
QL,QL01,QL01F,QL01FF,QL01FF01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,nivolumab
QL,QL01,QL01F,QL01FF,QL01FF02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,pembrolizumab
QL,QL01,QL01F,QL01FF,QL01FF03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,durvalumab
QL,QL01,QL01F,QL01FF,QL01FF04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,avelumab
QL,QL01,QL01F,QL01FF,QL01FF05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,atezolizumab
QL,QL01,QL01F,QL01FF,QL01FF06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,cemiplimab
QL,QL01,QL01F,QL01FF,QL01FF07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,dostarlimab
QL,QL01,QL01F,QL01FF,QL01FF08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,prolgolimab
QL,QL01,QL01F,QL01FF,QL01FF09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,tislelizumab
QL,QL01,QL01F,QL01FF,QL01FF10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,retifanlimab
QL,QL01,QL01F,QL01FF,QL01FF11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,sugemalimab
QL,QL01,QL01F,QL01FF,QL01FF12,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,serplulimab
QL,QL01,QL01F,QL01FF,QL01FF13,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors,toripalimab
QL,QL01,QL01F,QL01FG,QL01FG01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors,bevacizumab
QL,QL01,QL01F,QL01FG,QL01FG02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors,ramucirumab
QL,QL01,QL01F,QL01FX,QL01FX01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,edrecolomab
QL,QL01,QL01F,QL01FX,QL01FX02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,gemtuzumab ozogamicin
QL,QL01,QL01F,QL01FX,QL01FX03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,catumaxomab
QL,QL01,QL01F,QL01FX,QL01FX04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,ipilimumab
QL,QL01,QL01F,QL01FX,QL01FX05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,brentuximab vedotin
QL,QL01,QL01F,QL01FX,QL01FX06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,dinutuximab beta
QL,QL01,QL01F,QL01FX,QL01FX07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,blinatumomab
QL,QL01,QL01F,QL01FX,QL01FX08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,elotuzumab
QL,QL01,QL01F,QL01FX,QL01FX09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,mogamulizumab
QL,QL01,QL01F,QL01FX,QL01FX10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,olaratumab
QL,QL01,QL01F,QL01FX,QL01FX11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,bermekimab
QL,QL01,QL01F,QL01FX,QL01FX12,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,tafasitamab
QL,QL01,QL01F,QL01FX,QL01FX13,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,enfortumab vedotin
QL,QL01,QL01F,QL01FX,QL01FX14,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,polatuzumab vedotin
QL,QL01,QL01F,QL01FX,QL01FX15,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,belantamab mafodotin
QL,QL01,QL01F,QL01FX,QL01FX16,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,oportuzumab monatox
QL,QL01,QL01F,QL01FX,QL01FX17,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,sacituzumab govitecan
QL,QL01,QL01F,QL01FX,QL01FX18,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,amivantamab
QL,QL01,QL01F,QL01FX,QL01FX19,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,sabatolimab
QL,QL01,QL01F,QL01FX,QL01FX20,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,tremelimumab
QL,QL01,QL01F,QL01FX,QL01FX21,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,naxitamab
QL,QL01,QL01F,QL01FX,QL01FX22,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,loncastuximab tesirine
QL,QL01,QL01F,QL01FX,QL01FX23,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,tisotumab vedotin
QL,QL01,QL01F,QL01FX,QL01FX24,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,teclistamab
QL,QL01,QL01F,QL01FX,QL01FX25,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,mosunetuzumab
QL,QL01,QL01F,QL01FX,QL01FX26,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,mirvetuximab soravtansine
QL,QL01,QL01F,QL01FX,QL01FX27,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,epcoritamab
QL,QL01,QL01F,QL01FX,QL01FX28,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,glofitamab
QL,QL01,QL01F,QL01FX,QL01FX29,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Other monoclonal antibodies and antibody drug conjugates,talquetamab
QL,QL01,QL01F,QL01FY,QL01FY01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Combinations of monoclonal antibodies and antibody drug conjugates,pertuzumab and trastuzumab
QL,QL01,QL01F,QL01FY,QL01FY02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Combinations of monoclonal antibodies and antibody drug conjugates,nivolumab and relatlimab
QL,QL01,QL01F,QL01FY,QL01FY03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,Combinations of monoclonal antibodies and antibody drug conjugates,prolgolimab and nurulimab
QL,QL01,QL01X,QL01XA,QL01XA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,cisplatin
QL,QL01,QL01X,QL01XA,QL01XA02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,carboplatin
QL,QL01,QL01X,QL01XA,QL01XA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,oxaliplatin
QL,QL01,QL01X,QL01XA,QL01XA04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,satraplatin
QL,QL01,QL01X,QL01XA,QL01XA05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,polyplatillen
QL,QL01,QL01X,QL01XB,QL01XB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Methylhydrazines,procarbazine
QL,QL01,QL01X,QL01XD,QL01XD01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Sensitizers used in photodynamic/radiation therapy,porfimer sodium
QL,QL01,QL01X,QL01XD,QL01XD03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Sensitizers used in photodynamic/radiation therapy,methyl aminolevulinate
QL,QL01,QL01X,QL01XD,QL01XD04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Sensitizers used in photodynamic/radiation therapy,aminolevulinic acid
QL,QL01,QL01X,QL01XD,QL01XD05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Sensitizers used in photodynamic/radiation therapy,temoporfin
QL,QL01,QL01X,QL01XD,QL01XD06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Sensitizers used in photodynamic/radiation therapy,efaproxiral
QL,QL01,QL01X,QL01XD,QL01XD07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Sensitizers used in photodynamic/radiation therapy,padeliporfin
QL,QL01,QL01X,QL01XF,QL01XF01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Retinoids for cancer treatment,tretinoin
QL,QL01,QL01X,QL01XF,QL01XF02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Retinoids for cancer treatment,alitretinoin
QL,QL01,QL01X,QL01XF,QL01XF03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Retinoids for cancer treatment,bexarotene
QL,QL01,QL01X,QL01XG,QL01XG01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Proteasome inhibitors,bortezomib
QL,QL01,QL01X,QL01XG,QL01XG02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Proteasome inhibitors,carfilzomib
QL,QL01,QL01X,QL01XG,QL01XG03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Proteasome inhibitors,ixazomib
QL,QL01,QL01X,QL01XH,QL01XH01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Histone deacetylase (HDAC) inhibitors,vorinostat
QL,QL01,QL01X,QL01XH,QL01XH02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Histone deacetylase (HDAC) inhibitors,romidepsin
QL,QL01,QL01X,QL01XH,QL01XH03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Histone deacetylase (HDAC) inhibitors,panobinostat
QL,QL01,QL01X,QL01XH,QL01XH04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Histone deacetylase (HDAC) inhibitors,belinostat
QL,QL01,QL01X,QL01XH,QL01XH05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Histone deacetylase (HDAC) inhibitors,entinostat
QL,QL01,QL01X,QL01XJ,QL01XJ01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Hedgehog pathway inhibitors,vismodegib
QL,QL01,QL01X,QL01XJ,QL01XJ02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Hedgehog pathway inhibitors,sonidegib
QL,QL01,QL01X,QL01XJ,QL01XJ03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Hedgehog pathway inhibitors,glasdegib
QL,QL01,QL01X,QL01XK,QL01XK01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Poly (ADP-ribose) polymerase (PARP) inhibitors,olaparib
QL,QL01,QL01X,QL01XK,QL01XK02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Poly (ADP-ribose) polymerase (PARP) inhibitors,niraparib
QL,QL01,QL01X,QL01XK,QL01XK03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Poly (ADP-ribose) polymerase (PARP) inhibitors,rucaparib
QL,QL01,QL01X,QL01XK,QL01XK04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Poly (ADP-ribose) polymerase (PARP) inhibitors,talazoparib
QL,QL01,QL01X,QL01XK,QL01XK05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Poly (ADP-ribose) polymerase (PARP) inhibitors,veliparib
QL,QL01,QL01X,QL01XK,QL01XK06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Poly (ADP-ribose) polymerase (PARP) inhibitors,pamiparib
QL,QL01,QL01X,QL01XK,QL01XK52,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Poly (ADP-ribose) polymerase (PARP) inhibitors,niraparib and abiraterone
QL,QL01,QL01X,QL01XL,QL01XL01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,sitimagene ceradenovec
QL,QL01,QL01X,QL01XL,QL01XL02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,talimogene laherparepvec
QL,QL01,QL01X,QL01XL,QL01XL03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,axicabtagene ciloleucel
QL,QL01,QL01X,QL01XL,QL01XL04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,tisagenlecleucel
QL,QL01,QL01X,QL01XL,QL01XL05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,ciltacabtagene autoleucel
QL,QL01,QL01X,QL01XL,QL01XL06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,brexucabtagene autoleucel
QL,QL01,QL01X,QL01XL,QL01XL07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,idecabtagene vicleucel
QL,QL01,QL01X,QL01XL,QL01XL08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,lisocabtagene maraleucel
QL,QL01,QL01X,QL01XL,QL01XL09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,tabelecleucel
QL,QL01,QL01X,QL01XL,QL01XL10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,nadofaragene firadenovec
QL,QL01,QL01X,QL01XL,QL01XL11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Antineoplastic cell and gene therapy,lifileucel
QL,QL01,QL01X,QL01XX,QL01XX01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,amsacrine
QL,QL01,QL01X,QL01XX,QL01XX02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,asparaginase
QL,QL01,QL01X,QL01XX,QL01XX03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,altretamine
QL,QL01,QL01X,QL01XX,QL01XX05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,hydroxycarbamide
QL,QL01,QL01X,QL01XX,QL01XX07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,lonidamine
QL,QL01,QL01X,QL01XX,QL01XX08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,pentostatin
QL,QL01,QL01X,QL01XX,QL01XX10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,masoprocol
QL,QL01,QL01X,QL01XX,QL01XX11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,estramustine
QL,QL01,QL01X,QL01XX,QL01XX16,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,mitoguazone
QL,QL01,QL01X,QL01XX,QL01XX18,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,tiazofurin
QL,QL01,QL01X,QL01XX,QL01XX23,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,mitotane
QL,QL01,QL01X,QL01XX,QL01XX24,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,pegaspargase
QL,QL01,QL01X,QL01XX,QL01XX27,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,arsenic trioxide
QL,QL01,QL01X,QL01XX,QL01XX29,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,denileukin diftitox
QL,QL01,QL01X,QL01XX,QL01XX33,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,celecoxib
QL,QL01,QL01X,QL01XX,QL01XX35,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,anagrelide
QL,QL01,QL01X,QL01XX,QL01XX36,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,oblimersen
QL,QL01,QL01X,QL01XX,QL01XX40,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,omacetaxine mepesuccinate
QL,QL01,QL01X,QL01XX,QL01XX41,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,eribulin
QL,QL01,QL01X,QL01XX,QL01XX44,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,aflibercept
QL,QL01,QL01X,QL01XX,QL01XX52,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,venetoclax
QL,QL01,QL01X,QL01XX,QL01XX53,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,vosaroxin
QL,QL01,QL01X,QL01XX,QL01XX57,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,plitidepsin
QL,QL01,QL01X,QL01XX,QL01XX58,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,epacadostat
QL,QL01,QL01X,QL01XX,QL01XX59,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,enasidenib
QL,QL01,QL01X,QL01XX,QL01XX62,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,ivosidenib
QL,QL01,QL01X,QL01XX,QL01XX66,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,selinexor
QL,QL01,QL01X,QL01XX,QL01XX67,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,tagraxofusp
QL,QL01,QL01X,QL01XX,QL01XX69,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,lurbinectedin
QL,QL01,QL01X,QL01XX,QL01XX71,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,tisagenlecleucel
QL,QL01,QL01X,QL01XX,QL01XX72,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,tazemetostat
QL,QL01,QL01X,QL01XX,QL01XX73,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,sotorasib
QL,QL01,QL01X,QL01XX,QL01XX74,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,belzutifan
QL,QL01,QL01X,QL01XX,QL01XX75,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,tebentafusp
QL,QL01,QL01X,QL01XX,QL01XX77,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,adagrasib
QL,QL01,QL01X,QL01XX,QL01XX78,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,navitoclax
QL,QL01,QL01X,QL01XX,QL01XX79,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,eflornithine
QL,QL01,QL01X,QL01XX,QL01XX80,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,imetelstat
QL,QL01,QL01X,QL01XX,QL01XX91,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,tigilanol tiglate
QL,QL01,QL01X,QL01XX,QL01XX92,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,verdinexor
QL,QL01,QL01X,QL01XY,QL01XY01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Combinations of antineoplastic agents,cytarabine and daunorubicin
QL,QL02,QL02A,QL02AA,QL02AA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Estrogens,diethylstilbestrol
QL,QL02,QL02A,QL02AA,QL02AA02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Estrogens,polyestradiol phosphate
QL,QL02,QL02A,QL02AA,QL02AA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Estrogens,ethinylestradiol
QL,QL02,QL02A,QL02AA,QL02AA04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Estrogens,fosfestrol
QL,QL02,QL02A,QL02AB,QL02AB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Progestogens,megestrol
QL,QL02,QL02A,QL02AB,QL02AB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Progestogens,medroxyprogesterone
QL,QL02,QL02A,QL02AB,QL02AB03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Progestogens,gestonorone
QL,QL02,QL02A,QL02AE,QL02AE01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Gonadotropin releasing hormone analogues,buserelin
QL,QL02,QL02A,QL02AE,QL02AE02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Gonadotropin releasing hormone analogues,leuprorelin
QL,QL02,QL02A,QL02AE,QL02AE03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Gonadotropin releasing hormone analogues,goserelin
QL,QL02,QL02A,QL02AE,QL02AE04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Gonadotropin releasing hormone analogues,triptorelin
QL,QL02,QL02A,QL02AE,QL02AE05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Gonadotropin releasing hormone analogues,histrelin
QL,QL02,QL02A,QL02AE,QL02AE51,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Gonadotropin releasing hormone analogues,leuprorelin and bicalutamide
QL,QL02,QL02A,QL02AX,NA,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Other hormones,NA
QL,QL02,QL02B,QL02BA,QL02BA01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-estrogens,tamoxifen
QL,QL02,QL02B,QL02BA,QL02BA02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-estrogens,toremifene
QL,QL02,QL02B,QL02BA,QL02BA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-estrogens,fulvestrant
QL,QL02,QL02B,QL02BA,QL02BA04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-estrogens,elacestrant
QL,QL02,QL02B,QL02BB,QL02BB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,flutamide
QL,QL02,QL02B,QL02BB,QL02BB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,nilutamide
QL,QL02,QL02B,QL02BB,QL02BB03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,bicalutamide
QL,QL02,QL02B,QL02BB,QL02BB04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,enzalutamide
QL,QL02,QL02B,QL02BB,QL02BB05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,apalutamide
QL,QL02,QL02B,QL02BB,QL02BB06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,darolutamide
QL,QL02,QL02B,QL02BG,QL02BG01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Aromatase inhibitors,aminoglutethimide
QL,QL02,QL02B,QL02BG,QL02BG02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Aromatase inhibitors,formestane
QL,QL02,QL02B,QL02BG,QL02BG03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Aromatase inhibitors,anastrozole
QL,QL02,QL02B,QL02BG,QL02BG04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Aromatase inhibitors,letrozole
QL,QL02,QL02B,QL02BG,QL02BG05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Aromatase inhibitors,vorozole
QL,QL02,QL02B,QL02BG,QL02BG06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Aromatase inhibitors,exemestane
QL,QL02,QL02B,QL02BX,QL02BX01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Other hormone antagonists and related agents,abarelix
QL,QL02,QL02B,QL02BX,QL02BX02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Other hormone antagonists and related agents,degarelix
QL,QL02,QL02B,QL02BX,QL02BX03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Other hormone antagonists and related agents,abiraterone
QL,QL02,QL02B,QL02BX,QL02BX04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Other hormone antagonists and related agents,relugolix
QL,QL02,QL02B,QL02BX,QL02BX53,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Other hormone antagonists and related agents,abiraterone and prednisolone
QL,QL03,QL03A,QL03AA,QL03AA02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,filgrastim
QL,QL03,QL03A,QL03AA,QL03AA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,molgramostim
QL,QL03,QL03A,QL03AA,QL03AA09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,sargramostim
QL,QL03,QL03A,QL03AA,QL03AA10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,lenograstim
QL,QL03,QL03A,QL03AA,QL03AA12,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,ancestim
QL,QL03,QL03A,QL03AA,QL03AA13,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,pegfilgrastim
QL,QL03,QL03A,QL03AA,QL03AA14,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,lipegfilgrastim
QL,QL03,QL03A,QL03AA,QL03AA15,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,balugrastim
QL,QL03,QL03A,QL03AA,QL03AA16,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,empegfilgrastim
QL,QL03,QL03A,QL03AA,QL03AA17,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,pegteograstim
QL,QL03,QL03A,QL03AA,QL03AA18,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,efbemalenograstim alfa
QL,QL03,QL03A,QL03AA,QL03AA19,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,eflapegrastim
QL,QL03,QL03A,QL03AA,QL03AA90,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,pegbovigrastim
QL,QL03,QL03A,QL03AB,QL03AB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon alfa natural
QL,QL03,QL03A,QL03AB,QL03AB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon beta natural
QL,QL03,QL03A,QL03AB,QL03AB03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon gamma
QL,QL03,QL03A,QL03AB,QL03AB04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon alfa-2a
QL,QL03,QL03A,QL03AB,QL03AB05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon alfa-2b
QL,QL03,QL03A,QL03AB,QL03AB06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon alfa-n1
QL,QL03,QL03A,QL03AB,QL03AB07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon beta-1a
QL,QL03,QL03A,QL03AB,QL03AB08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon beta-1b
QL,QL03,QL03A,QL03AB,QL03AB09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,interferon alfacon-1
QL,QL03,QL03A,QL03AB,QL03AB10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,peginterferon alfa-2b
QL,QL03,QL03A,QL03AB,QL03AB11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,peginterferon alfa-2a
QL,QL03,QL03A,QL03AB,QL03AB12,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,albinterferon alfa-2b
QL,QL03,QL03A,QL03AB,QL03AB13,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,peginterferon beta-1a
QL,QL03,QL03A,QL03AB,QL03AB14,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,cepeginterferon alfa-2b
QL,QL03,QL03A,QL03AB,QL03AB15,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,ropeginterferon alfa-2b
QL,QL03,QL03A,QL03AB,QL03AB16,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,peginterferon alfacon-2
QL,QL03,QL03A,QL03AB,QL03AB17,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,sampeginterferon beta-1a
QL,QL03,QL03A,QL03AB,QL03AB60,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,"peginterferon alfa-2b, combinations"
QL,QL03,QL03A,QL03AB,QL03AB61,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,"peginterferon alfa-2a, combinations"
QL,QL03,QL03A,QL03AB,QL03AB90,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,"interferon omega, feline origin"
QL,QL03,QL03A,QL03AC,QL03AC01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interleukins,aldesleukin
QL,QL03,QL03A,QL03AC,QL03AC02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interleukins,oprelvekin
QL,QL03,QL03A,QL03AX,QL03AX01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,lentinan
QL,QL03,QL03A,QL03AX,QL03AX02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,roquinimex
QL,QL03,QL03A,QL03AX,QL03AX03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,BCG vaccine
QL,QL03,QL03A,QL03AX,QL03AX04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,pegademase
QL,QL03,QL03A,QL03AX,QL03AX05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,pidotimod
QL,QL03,QL03A,QL03AX,QL03AX07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,poly I:C
QL,QL03,QL03A,QL03AX,QL03AX08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,poly ICLC
QL,QL03,QL03A,QL03AX,QL03AX09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,thymopentin
QL,QL03,QL03A,QL03AX,QL03AX10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,immunocyanin
QL,QL03,QL03A,QL03AX,QL03AX11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,tasonermin
QL,QL03,QL03A,QL03AX,QL03AX12,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,melanoma vaccine
QL,QL03,QL03A,QL03AX,QL03AX13,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,glatiramer acetate
QL,QL03,QL03A,QL03AX,QL03AX14,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,histamine dihydrochloride
QL,QL03,QL03A,QL03AX,QL03AX15,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,mifamurtide
QL,QL03,QL03A,QL03AX,QL03AX16,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,plerixafor
QL,QL03,QL03A,QL03AX,QL03AX17,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,sipuleucel-T
QL,QL03,QL03A,QL03AX,QL03AX18,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,cridanimod
QL,QL03,QL03A,QL03AX,QL03AX19,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,dasiprotimut-T
QL,QL03,QL03A,QL03AX,QL03AX21,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,elapegademase
QL,QL03,QL03A,QL03AX,QL03AX22,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,leniolisib
QL,QL03,QL03A,QL03AX,QL03AX90,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,feline interleukin-2 recombinant canarypox virus
QL,QL04,QL04A,QL04AA,QL04AA03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,antilymphocyte immunoglobulin (horse)
QL,QL04,QL04A,QL04AA,QL04AA04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,antithymocyte immunoglobulin (rabbit)
QL,QL04,QL04A,QL04AA,QL04AA06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,mycophenolic acid
QL,QL04,QL04A,QL04AA,QL04AA15,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,alefacept
QL,QL04,QL04A,QL04AA,QL04AA19,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,gusperimus
QL,QL04,QL04A,QL04AA,QL04AA22,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,abetimus
QL,QL04,QL04A,QL04AA,QL04AA24,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,abatacept
QL,QL04,QL04A,QL04AA,QL04AA28,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,belatacept
QL,QL04,QL04A,QL04AA,QL04AA32,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,apremilast
QL,QL04,QL04A,QL04AA,QL04AA40,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,cladribine
QL,QL04,QL04A,QL04AA,QL04AA41,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,imlifidase
QL,QL04,QL04A,QL04AA,QL04AA48,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,belumosudil
QL,QL04,QL04A,QL04AA,QL04AA58,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,efgartigimod alfa
QL,QL04,QL04A,QL04AA,QL04AA90,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,fuzapladib
QL,QL04,QL04A,QL04AB,QL04AB01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Tumor necrosis factor alpha (TNF-alpha) inhibitors,etanercept
QL,QL04,QL04A,QL04AB,QL04AB02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Tumor necrosis factor alpha (TNF-alpha) inhibitors,infliximab
QL,QL04,QL04A,QL04AB,QL04AB03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Tumor necrosis factor alpha (TNF-alpha) inhibitors,afelimomab
QL,QL04,QL04A,QL04AB,QL04AB04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Tumor necrosis factor alpha (TNF-alpha) inhibitors,adalimumab
QL,QL04,QL04A,QL04AB,QL04AB05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Tumor necrosis factor alpha (TNF-alpha) inhibitors,certolizumab pegol
QL,QL04,QL04A,QL04AB,QL04AB06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Tumor necrosis factor alpha (TNF-alpha) inhibitors,golimumab
QL,QL04,QL04A,QL04AB,QL04AB07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Tumor necrosis factor alpha (TNF-alpha) inhibitors,opinercept
QL,QL04,QL04A,QL04AC,QL04AC01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,daclizumab
QL,QL04,QL04A,QL04AC,QL04AC02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,basiliximab
QL,QL04,QL04A,QL04AC,QL04AC03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,anakinra
QL,QL04,QL04A,QL04AC,QL04AC04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,rilonacept
QL,QL04,QL04A,QL04AC,QL04AC05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,ustekinumab
QL,QL04,QL04A,QL04AC,QL04AC07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,tocilizumab
QL,QL04,QL04A,QL04AC,QL04AC08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,canakinumab
QL,QL04,QL04A,QL04AC,QL04AC09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,briakinumab
QL,QL04,QL04A,QL04AC,QL04AC10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,secukinumab
QL,QL04,QL04A,QL04AC,QL04AC11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,siltuximab
QL,QL04,QL04A,QL04AC,QL04AC12,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,brodalumab
QL,QL04,QL04A,QL04AC,QL04AC13,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,ixekizumab
QL,QL04,QL04A,QL04AC,QL04AC14,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,sarilumab
QL,QL04,QL04A,QL04AC,QL04AC15,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,sirukumab
QL,QL04,QL04A,QL04AC,QL04AC16,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,guselkumab
QL,QL04,QL04A,QL04AC,QL04AC17,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,tildrakizumab
QL,QL04,QL04A,QL04AC,QL04AC18,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,risankizumab
QL,QL04,QL04A,QL04AC,QL04AC19,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,satralizumab
QL,QL04,QL04A,QL04AC,QL04AC20,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,netakimab
QL,QL04,QL04A,QL04AC,QL04AC21,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,bimekizumab
QL,QL04,QL04A,QL04AC,QL04AC22,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,spesolimab
QL,QL04,QL04A,QL04AC,QL04AC23,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,olokizumab
QL,QL04,QL04A,QL04AC,QL04AC24,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,mirikizumab
QL,QL04,QL04A,QL04AC,QL04AC25,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,levilimab
QL,QL04,QL04A,QL04AD,QL04AD01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,ciclosporin
QL,QL04,QL04A,QL04AD,QL04AD02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,tacrolimus
QL,QL04,QL04A,QL04AD,QL04AD03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,voclosporin
QL,QL04,QL04A,QL04AE,QL04AE01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Sphingosine-1-phosphate (S1P) receptor modulators,fingolimod
QL,QL04,QL04A,QL04AE,QL04AE02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Sphingosine-1-phosphate (S1P) receptor modulators,ozanimod
QL,QL04,QL04A,QL04AE,QL04AE03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Sphingosine-1-phosphate (S1P) receptor modulators,siponimod
QL,QL04,QL04A,QL04AE,QL04AE04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Sphingosine-1-phosphate (S1P) receptor modulators,ponesimod
QL,QL04,QL04A,QL04AE,QL04AE05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Sphingosine-1-phosphate (S1P) receptor modulators,etrasimod
QL,QL04,QL04A,QL04AF,QL04AF01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Janus-associated kinase (JAK) inhibitors,tofacitinib
QL,QL04,QL04A,QL04AF,QL04AF02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Janus-associated kinase (JAK) inhibitors,baricitinib
QL,QL04,QL04A,QL04AF,QL04AF03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Janus-associated kinase (JAK) inhibitors,upadacitinib
QL,QL04,QL04A,QL04AF,QL04AF04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Janus-associated kinase (JAK) inhibitors,filgotinib
QL,QL04,QL04A,QL04AF,QL04AF05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Janus-associated kinase (JAK) inhibitors,itacitinib
QL,QL04,QL04A,QL04AF,QL04AF06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Janus-associated kinase (JAK) inhibitors,peficitinib
QL,QL04,QL04A,QL04AF,QL04AF07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Janus-associated kinase (JAK) inhibitors,deucravacitinib
QL,QL04,QL04A,QL04AF,QL04AF08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Janus-associated kinase (JAK) inhibitors,ritlecitinib
QL,QL04,QL04A,QL04AG,QL04AG01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,muromonab-CD3
QL,QL04,QL04A,QL04AG,QL04AG02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,efalizumab
QL,QL04,QL04A,QL04AG,QL04AG03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,natalizumab
QL,QL04,QL04A,QL04AG,QL04AG04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,belimumab
QL,QL04,QL04A,QL04AG,QL04AG05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,vedolizumab
QL,QL04,QL04A,QL04AG,QL04AG06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,alemtuzumab
QL,QL04,QL04A,QL04AG,QL04AG07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,begelomab
QL,QL04,QL04A,QL04AG,QL04AG08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,ocrelizumab
QL,QL04,QL04A,QL04AG,QL04AG09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,emapalumab
QL,QL04,QL04A,QL04AG,QL04AG10,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,inebilizumab
QL,QL04,QL04A,QL04AG,QL04AG11,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,anifrolumab
QL,QL04,QL04A,QL04AG,QL04AG12,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,ofatumumab
QL,QL04,QL04A,QL04AG,QL04AG13,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,teprotumumab
QL,QL04,QL04A,QL04AG,QL04AG14,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,ublituximab
QL,QL04,QL04A,QL04AG,QL04AG15,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,divozilimab
QL,QL04,QL04A,QL04AG,QL04AG16,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,rozanolixizumab
QL,QL04,QL04A,QL04AG,QL04AG90,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Monoclonal antibodies,cirevetmab
QL,QL04,QL04A,QL04AH,QL04AH01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Mammalian target of rapamycin (mTOR) kinase inhibitors,sirolimus
QL,QL04,QL04A,QL04AH,QL04AH02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Mammalian target of rapamycin (mTOR) kinase inhibitors,everolimus
QL,QL04,QL04A,QL04AJ,QL04AJ01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,eculizumab
QL,QL04,QL04A,QL04AJ,QL04AJ02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,ravulizumab
QL,QL04,QL04A,QL04AJ,QL04AJ03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,pegcetacoplan
QL,QL04,QL04A,QL04AJ,QL04AJ04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,sutimlimab
QL,QL04,QL04A,QL04AJ,QL04AJ05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,avacopan
QL,QL04,QL04A,QL04AJ,QL04AJ06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,zilucoplan
QL,QL04,QL04A,QL04AJ,QL04AJ07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,crovalimab
QL,QL04,QL04A,QL04AJ,QL04AJ08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,iptacopan
QL,QL04,QL04A,QL04AJ,QL04AJ09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Complement inhibitors,danicopan
QL,QL04,QL04A,QL04AK,QL04AK01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Dihydroorotate dehydrogenase (DHODH) inhibitors,leflunomide
QL,QL04,QL04A,QL04AK,QL04AK02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Dihydroorotate dehydrogenase (DHODH) inhibitors,teriflunomide
QL,QL04,QL04A,QL04AX,QL04AX01,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,azathioprine
QL,QL04,QL04A,QL04AX,QL04AX02,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,thalidomide
QL,QL04,QL04A,QL04AX,QL04AX03,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,methotrexate
QL,QL04,QL04A,QL04AX,QL04AX04,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,lenalidomide
QL,QL04,QL04A,QL04AX,QL04AX05,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,pirfenidone
QL,QL04,QL04A,QL04AX,QL04AX06,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,pomalidomide
QL,QL04,QL04A,QL04AX,QL04AX07,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,dimethyl fumarate
QL,QL04,QL04A,QL04AX,QL04AX08,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,darvadstrocel
QL,QL04,QL04A,QL04AX,QL04AX09,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,diroximel fumarate
